Andrea Sitlinger

Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States

Anthony R. Mato, Meghan C. Thompson, John N. Allan et al. · Haematologica · 2018 · 165 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical Practice

Lindsey E. Roeker, Christopher P. Fox, Toby A. Eyre et al. · Clinical Cancer Research · 2019 · 90 citations · Full text

Pharmacy, Pharmacotherapy, Cancer Drug Toxicity Management +16

Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents

Lindsey E. Roeker, Peter Dreger, Jennifer R. Brown et al. · Blood Advances · 2020 · 86 citations · Full text

Medicine, Immunology, Oncology +17

The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Three-Factor Comorbidity Model

Max J. Gordon, Andy Kaempf, Andrea Sitlinger et al. · Clinical Cancer Research · 2021 · 53 citations · Full text

Public Health, Biostatistics, Oncology +17

Phase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3Kδ inhibitor therapy

Anthony R. Mato, Nilanjan Ghosh, Stephen J. Schuster et al. · Blood · 2020 · 49 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8